Jiangsu Nanfang Medical (603880) — Cash Flow-to-Debt Ratio
Jiangsu Nanfang Medical (603880) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of CN¥12.53 Million could theoretically repay 0% of its total liabilities (CN¥733.89 Million) in one year. See Jiangsu Nanfang Medical free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Jiangsu Nanfang Medical Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Jiangsu Nanfang Medical across 14 annual periods. Also explore Jiangsu Nanfang Medical net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Jiangsu Nanfang Medical (2012–2025)
Year-by-year debt coverage analysis for Jiangsu Nanfang Medical. For market capitalisation and broader financial context, see market cap of Jiangsu Nanfang Medical.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.06x | CN¥47.73 Million | CN¥746.77 Million | ▼ -22.1% |
| 2024 | 0.08x | CN¥63.32 Million | CN¥772.14 Million | ▲ +324.6% |
| 2023 | 0.02x | CN¥15.51 Million | CN¥803.11 Million | ▼ -48.4% |
| 2022 | 0.04x | CN¥31.28 Million | CN¥835.75 Million | ▲ +125.8% |
| 2021 | -0.15x | CN¥-84.25 Million | CN¥580.29 Million | ▼ -135.0% |
| 2020 | 0.41x | CN¥154.12 Million | CN¥371.84 Million | ▲ +279.5% |
| 2019 | 0.11x | CN¥32.99 Million | CN¥302.08 Million | ▼ -40.8% |
| 2018 | 0.18x | CN¥52.75 Million | CN¥285.78 Million | ▲ +7.0% |
| 2017 | 0.17x | CN¥49.24 Million | CN¥285.40 Million | ▼ -54.9% |
| 2016 | 0.38x | CN¥99.35 Million | CN¥259.87 Million | ▲ +5.8% |
| 2015 | 0.36x | CN¥90.66 Million | CN¥250.86 Million | ▲ +11.2% |
| 2014 | 0.33x | CN¥73.52 Million | CN¥226.10 Million | ▲ +230.6% |
| 2013 | 0.10x | CN¥20.14 Million | CN¥204.78 Million | ▼ -66.6% |
| 2012 | 0.29x | CN¥76.07 Million | CN¥258.41 Million | — |